NeuroPointDX, through its parent company Stemina Biomarker Discovery, has published papers in peer-reviewed journals and presented research at meetings around the world.
- The Children’s Autism Metabolome Project (CAMP) was the largest study to date to evaluate the metabolism of childre… https://t.co/QPXCK0ICpV2 days ago
- Which environment is better for the delivery of autism intervention services? Home or an autism research center? Th… https://t.co/n057kPdpU22 days ago
- Though about half of people with autism also have an intellectual disability, a recent meta-analysis of 100s of aut… https://t.co/dDGzFFRDSD2 days ago